Investor Overview
VYNE Therapeutics™ is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.40
May. 19, 2022 11:13:12- Change 0.0002 (0.05002586%)
- Volume 60,211
- Today's Open 0.4158
- Previous Close 0.3998
- Today's High 0.42
- Today's Low 0.4
- 52 Week High 4.24
- 52 Week Low 0.34
VYNE Therapeutics™ is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding VYNE Therapeutic’s performance made by these analysts are theirs alone, and do not represent opinions, forecasts or predictions of VYNE Therapeutics or its management. VYNE Therapeutics does not, by its reference below imply its endorsement of or concurrence with such analysts’ information, conclusions or recommendations.
- Louise Chen: Cantor Fitzgerald
- Balaji V Prasad: Barclays
- Raghuram Selvaraju: HC Wainwright & Co LLC
- Patrick Dolezal: LifeSci Capital
- Casey Lea: ISS-EVA
- Ken Cacciatore: Cowen
- Tim Chiang: Northland Capital Markets